HIV-1 infectivity and host range modification by cathepsin D present in human vaginal secretions

AIDS

Volumn 13, Issue 3, 1999, Pages 333-339

  Ei Messaoudi, Kamal ^a   Thiry, Lise ^a   Van Tieghem, Nicole ^a   Liesnard, Corinne ^a   Englert, Yvon ^a   Moguilevsky, Nicole ^a   Bollen, Alex ^a,b  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

AIDS; Genital secretions; Proteases; Receptors; Sexual transmission

Indexed keywords

ALPHA CHEMOKINE; ASPARTIC PROTEINASE; BLOCKING ANTIBODY; CATHEPSIN D; CD4 ANTIGEN; CELL RECEPTOR; MONOCLONAL ANTIBODY; OKT 4; PEPSTATIN;

AGAR GEL ELECTROPHORESIS; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; LYMPHOCYTE CULTURE; NORMAL HUMAN; PRIORITY JOURNAL; VAGINA EPITHELIUM; VAGINA SECRETION; VIRUS INFECTIVITY;

CATHEPSIN D; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; RECEPTORS, CCR5; RECEPTORS, CXCR4; VAGINA;

EID: 0032968948     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199902250-00005     Document Type: Article

References (27)

1. Rasheed S, Zhiliang L, Xu D, et al.: Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women. Am J Obstet Gynecol 1996, 175:122-130
2. O'Shea S, de Ruiter A, Mullen J, et al.: Quantification of HIV-1 RNA in cervicovaginal secretions: an improved method of sample collection [letter]. AIDS 1997, 11:1056-1058
3. Zhu T., Wang N., A. Carr A, et al.: Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J Virol 1996, 70:3098-3107
4. Garten W, Bosch FX, Linder D, et al.: Proteolytic activation of the influenza virus hemagglutinin: the structure of the cleavage site and the enzymes involved in cleavage. Virology 1981, 151:361-374
5. Sondrag L, Choppin P: Enhancement of the infectivity of influenza A and B virus by proteolytic cleavage of the hemagglutinin polypeptide. Virology 1975, 68:440-454
6. Andersen KB, Skov H: Retrovirus-induced cell fusion is enhanced by protease treatment. J Gen Virol 1989, 70 (Pt 7):1921-1927
7. Tashiro M, Homma M: Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs. Infect Immun 1983, 39:679-881
8. Tashiro M, Yokogoshi Y, Tobita K, Seto JT, Rott R, Kido H: Tryptase Clara, an activating protease for Sendai virus in rat lung cells, is involved in pneumopathogenicity. J Virol 1992, 66:7211-7216
9. Barbey-Morel CL, Oeltmann TN, Edwards KM, et al.: Role of respiratory proteases in infectivity of influenza A virus. J Infect Dis 1987, 155:667-672
10. Kärber G: Beitrag zur kollektiven behandlung pharmakologischer reihneversuche Arch Exp Pathol Pharmakol 1931, 2:480-483
11. Garcia M, Capony F, Derocq D, et al.: Characterization of monoclonal antibodies to the estrogen-regulated Mr 52,000 glycoprotein and their use in MCF7 cells. Cancer Res 1985, 45:709-716
12. Laemmli UK: Cleavage of structural proteins during assembly of the bacteriophage T3. Nature 1970, 227:680-6850
13. Takahashi T, Tang J: Cathepsin D from porcine spleen cells. Method Enzymol 1981, 80:565-580
14. Raport CJ, Gosling J, Scheickart VL, Gray PW, Charo IF: Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for Rantes, MIP-1β, and MIP-1α. J Biol Chem 1996, 271:17161-17166
15. Clements GJ, Price-Jones MJ, Stephens PE, et al.: The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion. AIDS Res Hum Retroviruses 1991, 7:3-16
16. Tang S, Levy JA: Inactivation of HIV-1 by trypsin and its use in demonstrating specific infection of cells. J Virol 1991, 33:39-46
17. Arnold D, Keilholz W, Schild H, Dumrese T, Stevanovic S, Rammensee HG: Substrate specificity of cathepsins D and E determined by N-terminal and C-terminal sequencing of peptide pools, Eur J Biochem 1997, 249:171-179
18. Moulton BC, Koenig BB: Progestin increases cathepsin D synthesis in uterine epithelial cells. Am J Physiol 1983, 244:442-446
19. Kainz C, Wagner O, Bieglmayr C, et al.: Proteolytic enzyme cathepsin D in follicular fluids and its possible role in ovulation. Horm Metab Res 1994, 26:444-445
20. Maudelonge T, Martinez P, Brouillet JP, Laffargue F, Pages A, Rochefort H: Cathepsin D in human endometrium: induction by progesterone and potential value as a tumor marker. J Clin Endocr Metab 1990, 70:115-121
21. Dezutter-Dambuyant C, Schmitt DA, Dusserre N, et al.: Trypsinresistant gp120 receptors are upregulated on short-time cultured human epidermal Langerhans cells. Res Virol 1991, 142:129-138
22. Spear GT, Al-Harthi L, Sha B, et al.: A potent activator of HIV-1 replication is present in the genital tract of a subset of HIV-1-infected and uninfected women. AIDS 1997, 11:1319-1326
23. Fantini J, Yahi N, Tourres C, Delezay O, Tamalet C: HIV-1 transmission across the vaginal epithelium [letter]. AIDS 1997, 11:1663-1664
24. Tan X, Phillips DM: Cell-mediated infection of cervix derived epithelial cells with primary isolates of human immune deficiency virus. Arch Virol 1996, 141:1177-1189
25. Howell AL, Edkins RD, Rier SE, et al.: Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract. J Virol 1997, 71:3498-3506
26. Spira AI, Marx PA, Patterson BK, et al.: Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immune deficiency virus into rhesus macaques. J Exp Med 1996, 183:215-222
27. Chan DC, Kim PS: HIV entry and its inhibition. Cell 1998, 93:681-684